In Reply to "Chelation Therapy for Kidney Transplant Recipients With Lead Exposure"

Am J Kidney Dis. 2023 Jan;81(1):118-119. doi: 10.1053/j.ajkd.2022.09.008. Epub 2022 Oct 24.

Authors

Camilo G Sotomayor¹, Daan J Touw², Stephan J L Bakker¹; TransplantLines Investigators

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

PMID: 36302444
DOI: 10.1053/j.ajkd.2022.09.008

No abstract available

Publication types

Letter
Comment

MeSH terms

Chelation Therapy
Edetic Acid
Humans
Kidney Transplantation*
Lead

Substances

Lead
Edetic Acid